Podcast description: centenarian genetics, aging drugs and biological age with Dr. Nir Barzilai
Thumbnail from YouTube. Playing loads the YouTube player.
History & recommendationsOff
Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.
Open saved items & history →At a glance
Automatic summary · not editorially reviewedAccording to the description, Dr. Nir Barzilai discusses protective genes in centenarians, growth hormone and IGF-1, metformin and other drugs aimed at aging biology, peptides, supplements and biological age testing. The description frames the goal as compressing illness, not living forever. [1]
The description says Dr. Barzilai studies protective genes that may delay aging and age-related diseases in centenarians. [1]
The description says growth hormone and IGF-1 may affect aging differently depending on biological age. [1]
The description asks whether biological age tests really measure aging. [1]
Centenarians, protective genes and healthspan
The description says Dr. Barzilai studies protective genes that may delay aging and age-related diseases in centenarians. It asks why some people live beyond 100 despite smoking, being overweight and not following a perfect health routine, and says exceptional longevity is not just about diet, exercise or supplements. The description attributes these points to the podcast discussion; it gives no study numbers, participant counts or follow-up. [1]
Hormones, metformin and drugs targeting aging
The description says growth hormone and IGF-1 may affect aging differently depending on biological age, and that hormones affect aging differently after 50. It names metformin, GLP-1 drugs, SGLT2 inhibitors and other gerotherapeutics as possible ways to target aging biology rather than single diseases, and mentions the TAME trial on metformin and aging. It also covers MOTS-c and Humanin peptides and the risks of unregulated peptide injections. No results or effect sizes are reported. [1]
Supplements, oxygen therapy and biological age tests
The description lists longevity supplements, vitamin D, hyperbaric oxygen therapy, stem cells, rapamycin and biological age testing as topics, and asks whether biological age tests really measure aging. It also asks when targeting biological aging should start and whether human lifespan could reach 120. These are described as discussion topics, not as established benefits; the description reports no outcomes for any of them. [1]
Context & limits
This is only the video description; the video and transcript were not reviewed. It reports no study design, sample size, follow-up or results, and the topics are attributed to the podcast discussion.
Based on the creator’s description; the full video and transcript were not analyzed.
Quoted passages in the original language
protective genes that help delay aging
depending on our biological age
Can Biological Age Tests Really Measure Aging
About this video
Creator description · original textText language: English
Ayık Kafa · 63 min · Source published: 2026-10-15
Added to Harbor: 10/23/2026
Original on YouTube ↗Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.